Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
| Product: | Ibuprofen 200 (General sale) |
| Active Ingredient: | Ibuprofen 200mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | PSM Healthcare Limited trading as API Consumer Brands |
| Manufacturer: | Medreich Limited, Bangalore, India |
| Product: | Ibuprofen 200 (Pharmacy only) |
| Active Ingredient: | Ibuprofen 200mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | PSM Healthcare Limited trading as API Consumer Brands |
| Manufacturer: | Medreich Limited, Bangalore, India |
| Product: | Remicade |
| Active Ingredient: | Infliximab 100mg |
| Dosage Form: | Powder for injection |
| New Zealand Sponsor: | Janssen-Cilag (New Zealand) Limited |
| Manufacturers: | Patheon Italia SpA, Monza, Italy Cilag AG, Schaffhausen, Switzerland MSD International GmbH (Singapore Branch), Singapore City, Singapore |
Dated this 2nd day of July 2021.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).